Vaderis is a company headquartered in Switzerland.
Vaderis is a biotech company developing targeted therapies for Hereditary Hemorrhagic Telangiectasia (HHT) and other rare vascular diseases to address unmet medical needs with no currently approved treatments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.